Tetraphase Pharmaceuticals Cash Flow - Quarterly (NASDAQ:TTPH)

Add to My Stocks
$3.16 $0.15 (4.98%) TTPH stock closing price Sep 20, 2018 (Closing)

The cash flow statement is one of the reports a publicly traded company like Tetraphase Pharmaceuticals needs to disclose. While its important to look at the Tetraphase Pharmaceuticals debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Tetraphase Pharmaceuticals revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. Tetraphase Pharmaceuticals stock analysis shows negative net income cash flow of $-31.12M till 2018 Q2. This statement is important because profits alone cannot pay employees, or bills. Cash is required. TTPH decrease in investments stood at a value of $-0.09M for the latest quarter 2018 Q2.

View and download details of Tetraphase Pharmaceuticals cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
-31.12M-21.57M-114.75M-91.27M-61.26M-29.45M-77.48M-55.01M-33.9M-16.74M
Depreciation Depletion Amortization Cash-Flow----------
Net Increase (Decrease) in Assets Liabilities-5.68M-0.4M4.3M10.33M9.63M7.54M---0.75M-3.49M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net6.36M2.97M11.96M9.35M6.23M3.07M13.14M10.31M6.98M4.17M
Net Cash from (used by) Operating Activities
-30.2M-18.89M-98.05M-71.26M-45.19M-18.74M-63.76M-43.84M-27.54M-15.99M
Increase (Decrease) in Prop Plant And Equipment-0.09M-0.08M-0.77M-0.68M-0.67M-0.5M-0.39M-0.19M-0.17M-0.07M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
-0.09M-0.08M-0.77M-0.68M-0.67M-0.5M-0.39M-0.19M-0.17M-0.07M
Issuance (Purchase) of Equity Shares5.08M-93.14M91.22M21.99M5.32M----
Issuance (Repayment) of Debt Securities----------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities----------
Net Cash from (used by) Financing Activities
5.08M-93.14M91.22M21.99M5.32M----
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
-25.21M-18.74M-5.67M19.27M-23.87M-13.92M-63.82M-43.83M-27.6M-16.04M
Cash & Equivalents at Beginning of Year136.61M142.08M205.91M121.04M102.71M9.07M22.45M34.58M--
Cash & Equivalents at Year End111.4M117.86M136.41M161.36M118.21M128.15M142.08M162.07M178.31M189.86M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Tetraphase Pharmaceuticals stock comparison chart provides an easy way to compare the stock price with peers along with details of Tetraphase Pharmaceuticals stock price history.
The statement of cash flows can be categorized into the following main sections:

  • Tetraphase Pharmaceuticals saw a negative change in Net Change in Cash and Cash Equivalents of $-25.21M till 2018 Q2. Apart from the Tetraphase Pharmaceuticals stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: Tetraphase Pharmaceuticals reported a negative operating cash flow of $-30.2M till 2018 Q2 and has seen a decrease from the previous quarter. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash from investing stood at a negative value of $-0.09M for TTPH stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Tetraphase Pharmaceuticals earned $5.08M from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For Tetraphase Pharmaceuticals Cash Flow